Antigen presentation and antigen-presenting cells in graft-versus-host disease - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 188

[63] Mapara MY, Kim YM, Wang SP, Bronson R, Sachs DH, Sykes M. Donor lympho-
cyte infusions mediate superior graft-versus-leukemia effects in mixed compared
to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood
2002;100(5):1903-9.
[64] MacDonald KPA, Kuns RD, Rowe V, Morris ES, Banovic T, Bofinger H, et al. Effector and
regulatory T-cell function is differentially regulated by RelB within antigen-presenting
cells during GVHD. Blood 2007;109(11):5049-57.
[65] Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, et al. Effective-
ness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.
Science 2002;295(5562):2097-100.
[66] Korngold R, Sprent J. Negative selection of T cells causing lethal graft-versus-host
disease across minor histocompatibility barriers: role of the H-2 complex. J Exp Med
1980;151(5):1114-24.
[67] Korngold R, Sprent J. Features of T cells causing H-2-restricted lethal graft-versus-host
disease across minor histocompatibility barriers. J Exp Med 1982;155(3):872-83.
[68] Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, et al. Prevention
of graft versus host disease by inactivation of host antigen-presenting cells. Science
1999;285(5426):412-5.
[69] Reddy P, Maeda Y, Liu C, Krijanovski OI, Korngold R, Ferrara JL. A crucial role for
antigen-presenting cells and alloantigen expression in graft-versus-leukemia respons-
es. Nat Med 2005;11(11):1244-9.
[70] Matte-Martone C, Venkatesan S, Tan HS, Athanasiadis I, Chang J, Pavisic J, et al. Graft-
versus-leukemia (GVL) against mouse blast-crisis chronic myelogenous leukemia
(BC-CML) and chronic-phase chronic myelogenous leukemia (CP-CML): shared
mechanisms of T cell killing, but programmed death ligands render CP-CML and not
BC-CML GVL resistant. J Immunol 2011;187(4):1653-63.
[71] Anderson BE, McNiff JM, Jain D, Blazar BR, Shlomchik WD, Shlomchik MJ. Dis-
tinct roles for donor- and host-derived antigen-presenting cells and costimulatory
molecules in murine chronic graft-versus-host disease: requirements depend on target
organ. Blood 2005;105(5):2227-34.
[72] Anderson BE, McNiff J, Yan J, Doyle H, Mamula M, Shlomchik MJ, et al. Memory
CD4+ T cells do not induce graft-versus-host disease. J Clin Invest 2003;112(1):
101-8.
[73] Chen BJ, Cui X, Liu C, Chao NJ. Prevention of graft-versus-host disease while preserv-
ing graft-versus-leukemia effect after selective depletion of host-reactive T cells by
photodynamic cell purging process. Blood 2002;99(9):3083-8.
[74] Beilhack A, Schulz S, Baker J, Beilhack GF, Wieland CB, Herman EI, et al. In vivo
analyses of early events in acute graft-versus-host disease reveal sequential infiltration
of T-cell subsets. Blood 2005;106(3):1113-22.
[75] Moon JJ, Chu HH, Pepper M, McSorley SJ, Jameson SC, Kedl RM, et al. Naive CD4(+)
T cell frequency varies for different epitopes and predicts repertoire diversity and
response magnitude. Immunity 2007;27(2):203-13.
[76] Hataye J, Moon JJ, Khoruts A, Reilly C, Jenkins MK. Naive and memory CD4+ T cell
survival controlled by clonal abundance. Science 2006;312(5770):114-6.
[77] Germain RN, Bajénoff M, Castellino F, Chieppa M, Egen JG, Huang AYC, et al. Mak-
ing friends in out-of-the-way places: how cells of the immune system get together
and how they conduct their business as revealed by intravital imaging. Immunol Rev
2008;221(1):163-81.
[78] Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, Germain RN. Chemo-
kines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic
cell interaction. Nature 2006;440(7086):890-5.
[79] Anderson BE, Taylor PA, McNiff JM, Jain D, Demetris AJ, Panoskaltsis-Mortari A, et al.
Effects of donor T-cell trafficking and priming site on graft-versus-host disease induc-
tion by naive and memory phenotype CD4 T cells. Blood 2008;111(10):5242-51.
[80] Silva IA, Olkiewicz K, Askew D, Fisher JM, Chaudhary MN, Vannella KM, et al.
Secondary lymphoid organs contribute to, but are not required for the induction
of graft-versus-host responses following allogeneic bone marrow transplanta-
tion: a shifting paradigm for T cell allo-activation. Biol Blood Marrow Transplant
2010;16(5):598-611.
[81] Beilhack A, Schulz S, Baker J, Beilhack GF, Nishimura R, Baker EM, et al. Prevention of
acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs.
Blood 2008;111(5):2919-28.
[82] Toubai T, Tawara I, Sun Y, Liu C, Nieves E, Evers R, et al. Induction of acute GVHD
by sex-mismatched H-Y antigens in the absence of functional radiosensitive host
hematopoietic-derived antigen presenting cells. Blood 2012;119(16):3844-53.

191